Elevated serum parathyroid hormone is a cardiovascular risk factor in moderate chronic kidney disease

No abstract is available for this paper.

• Publication year

  2012

• Venue

  International Urology and Nephrology

• Publication date

  2012-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11255-010-9897-2PMID 21327525
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vitamin d, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study.

  2010cited by this paper
• Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography.

  2010cited by this paper
• Association of Secondary Hyperparathyroidism with CKD Progression, Health Care Costs and Survival in Diabetic Predialysis CKD Patients

  2009cited by this paper
• Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease.

  2009cited by this paper
• Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).

  2009cited by this paper
• Plasma Parathyroid Hormone and the Risk of Cardiovascular Mortality in the Community

  2009cited by this paper
• Secondary hyperparathyroidism is associated with higher mortality in men with moderate to severe chronic kidney disease.

  2008cited by this paper
• Association of mineral metabolism factors with all‐cause and cardiovascular mortality in hemodialysis patients: The Japan dialysis outcomes and practice patterns study

  2007cited by this paper
• Prevalence of chronic kidney disease in the United States.

  2007cited by this paper
• Circulating leptin and adiponectin levels in patients with primary hyperparathyroidism.

  2007cited by this paper
• Is early chronic kidney disease an important risk factor for cardiovascular disease? A background paper prepared for the UK Consensus Conference on early chronic kidney disease.

  2007cited by this paper
• Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through protein kinase pathways.

  2007cited by this paper
• Vascular calcification: contribution of parathyroid hormone in renal failure.

  2007cited by this paper
• Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study.

  2005cited by this paper
• Increased plasma N‐terminal pro‐B‐type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism

  2005cited by this paper
• Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study.

  2005cited by this paper
• Serum parathyroid hormone levels predict coronary heart disease: the Tromsø Study

  2004cited by this paper
• Higher impact of mineral metabolism on cardiovascular mortality in a European hemodialysis population.

  2003cited by this paper
• Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

  2003cited by this paper
• Parathyroid hormone and left ventricular hypertrophy.

  2003cited by this paper
• Parathyroid Hormone Has a Prosclerotic Effect on Vascular Smooth Muscle Cells

  2002cited by this paper
• The severity of secondary hyperparathyroidism in chronic renal insufficiency is GFR-dependent, race-dependent, and associated with cardiovascular disease.

  2002cited by this paper
• Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism.

  1999cited by this paper
• Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy

  1999cited by this paper
• Increased expression of parathyroid hormone-related peptide gene in blood vessels of spontaneously hypertensive rats.

  1997cited by this paper
• Distribution of parathyroid hormone-2 receptor messenger ribonucleic acid in rat.

  1996cited by this paper
• Endothelium is a target organ of parathyroid secretions in genetic hypertensive rats.

  1995cited by this paper
• The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein.

  1995cited by this paper
• Secondary hyperparathyroidism in renal failure: the trade-off hypothesis revisited.

  1995cited by this paper
• PTH, chronic renal failure and myocardium.

  1995cited by this paper
• Relation between parathyroid hormone and cardiac function in long-term hemodialysis patients.

  1995cited by this paper
• A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia.

  1994cited by this paper
• Trophic effects of catecholamines and parathyroid hormone on adult ventricular cardiomyocytes.

  1992cited by this paper
• On the mechanism of impaired insulin secretion in chronic renal failure.

  1991cited by this paper
• Left ventricular hypertrophy in end-stage renal disease.

  1988cited by this paper
• Role of parathyroid hormone in the glucose intolerance of chronic renal failure.

  1985cited by this paper
• Uraemic arterial disease. An experimental study with special reference to the effect of parathyroidectomy.

  1979cited by this paper

• Hormonal and mineral dysregulation determines the dynamics of calcification in adenine-induced CKD in male rats.

  2025cites this paper
• Parathyroid Hormone Levels as an Independent Predictor of Ischemic Heart Disease in Stage 3–5 Non-Dialysis Chronic Kidney Disease: A Retrospective Cohort Study

  2025cites this paper
• Impact of Surgical Parathyroidectomy on Craniofacial Morphology in Patients With Renal Failure

  2024cites this paper
• Skeletal Muscle Injury in Chronic Kidney Disease—From Histologic Changes to Molecular Mechanisms and to Novel Therapies

  2024cites this paper
• Proteomic Assessment of the Risk of Secondary Cardiovascular Events among Individuals with CKD

  2024cites this paper
• Evaluation of MicroRNA 145 and MicroRNA 155 as Markers of Cardiovascular Risk in Chronic Kidney Disease

  2024cites this paper
• The calcium-clot connection: investigating the association between primary hyperparathyroidism and acute venous thromboembolism

  2023cites this paper
• Complications et prise en charge thérapeutique des anomalies du métabolisme phosphocalcique de l’insuffisance rénale chronique

  2023cites this paper
• 'Phos'tering a clear message: the evolution of dietary phosphorus management in chronic kidney disease.

  2023cites this paper
• Biochemical spectrum of parathyroid hormone disorders in patients attending Tribhuvan University Teaching Hospital, Kathmandu, Nepal

  2023cites this paper
• Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association

  2023cites this paper
• Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study

  2023cites this paper
• Study of left ventricular systolic dysfunction, left ventricular diastolic dysfunction and pulmonary hypertension in CKD 3b-5ND patients-A single centre cross-sectional study.

  2022cites this paper
• Ambulatory Parathyroidectomy for Secondary Hyperparathyroidism at a Large Dialysis Program in Toronto: A Program Report

  2022cites this paper
• Parathyroid Hormone Induces Human Valvular Endothelial Cells Dysfunction That Impacts the Osteogenic Phenotype of Valvular Interstitial Cells

  2022influential citation
• Hyperparathyroidism and Associated Factors in Chronic Kidney Disease

  2022cites this paper
• Relationship between intact parathyroid hormone and all-cause death, cardiovascular events, and ectopic calcification in patients with diabetic kidney disease: A retrospective study.

  2021cites this paper
• Impact of nutritional vitamin D supplementation on parathyroid hormone and 25-hydroxyvitamin D levels in non-dialysis chronic kidney disease: a meta-analysis

  2021cites this paper
• INCIDENCE OF IRREGULAR PARATHYROID HORMONE IN PATIENTS OF RENAL FAILURE PLANNED TO UNDERGO HEMODIALYSIS

  2021cites this paper
• The association between Hba1c and arterial stiffness among non-diabetic patients with chronic kidney disease

  2021cites this paper
• Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease

  2021cites this paper
• Renal Contributions in the Pathophysiology and Neuropathological Substrates Shared by Chronic Kidney Disease and Alzheimer’s Disease

  2020cites this paper
• Optimal blood pressure for the minimum all-cause mortality in Chinese ESRD patients on maintenance hemodialysis

  2020cites this paper
• Cost-Effectiveness and Estimated Health Benefits of Treating Patients with Vitamin D in Pre-Dialysis

  2020cites this paper
• Parathyroid Hormone: A Uremic Toxin

  2020cites this paper
• Asymmetric dimethylarginine and angiopoietin-like protein-2 are independent predictors of cardiovascular risk in pre-dialysis non-diabetic chronic kidney disease patients

  2020cites this paper
• Cardiovascular Risk Factors in Pre-dialysis Chronic Kidney Disease patients of Nepal

  2020cites this paper
• Relationship between parathyroid hormone and renin–angiotensin–aldosterone system in hemodialysis patients with secondary hyperparathyroidism

  2020cites this paper
• Chronic Kidney Disease as Oxidative Stress- and Inflammatory-Mediated Cardiovascular Disease

  2020cites this paper
• Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 Diabetes.

  2020cites this paper
• Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease

  2019cites this paper
• Evaluating extended-release calcifediol as a treatment option for chronic kidney disease-mineral and bone disorder (CKD-MBD)

  2019cites this paper
• The cost-effectiveness of extended-release calcifediol versus paricalcitol for the treatment of secondary hyperparathyroidism in stage 3–4 CKD

  2019cites this paper
• Evolving concepts in the pathogenesis of uraemic cardiomyopathy

  2019cites this paper
• Postsurgical Evaluation of Secondary Nephrogenic Hyperparathyroidism

  2019cites this paper
• A Novel Perspective Linkage Between Kidney Function and Alzheimer’s Disease

  2018cites this paper
• Association between Parathyroid Hormone and Cardiovascular Disease

  2018cites this paper
• Severe secondary hyperparathyroidism in patients on haemodialysis is associated with a high initial serum parathyroid hormone and beta-CrossLaps level: Results from an incident cohort

  2018cites this paper
• Underrecognition and Underestimation of Disturbances in Calcium-Phosphate Balance in Kidney Transplant Recipients.

  2018cites this paper
• Cardiotoxicity of Uremic Toxins: A Driver of Cardiorenal Syndrome

  2018cites this paper
• The Relationship between Primary Hyperparathyroidism and Thrombotic Events: Report of Three Cases and a Review of Potential Mechanisms

  2018cites this paper
• Relationship between Parathyroid Hormone Levels and Hazards of Fracture, Vascular Events and Death in Stage 3 and 4 Chronic Kidney Disease

  2018cites this paper
• Parathyroid Hormone Levels in the Prediction of Ischemic Stroke Risk

  2017cites this paper
• THE IMPACT OF SECONDARY HYPERPARATHYROIDISM ON ECHOCARDIOGRAPHIC PARAMETERS IN HEMODIALYSIS PATIENTS

  2017cites this paper
• [Management of bone and mineral metabolism disorders before the dialysis stage remains still perfectible. Data from the French Phosphorus and Calcium Survey Photo-Graphe].

  2017cites this paper
• Bioactive Vitamin D Therapy to Treat Secondary Hyperparathyroidism in Pre-Dialysis Chronic Kidney Disease: A Systematic Review

  2017cites this paper
• The Parathyroid Gland and Heart Disease.

  2017cites this paper
• Parathyroid hormone promotes osteoblastic differentiation of endothelial cells via the extracellular signal-regulated protein kinase 1/2 and nuclear factor-κB signaling pathways.

  2017cites this paper
• Increased risk of cardiovascular diseases results from accelerated development of atherosclerosis in patients with chronic renal disease

  2017cites this paper
• Associations of parathyroid hormone levels and mineral parameters with heart rate variability in patients with end-stage renal disease

  2017cites this paper
• Secondary Hyperparathyroidism in Heart Failure

  2017cites this paper
• Effects of lanthanum carbonate on vascular calcification in elderly maintenance hemodialysis patients

  2015cites this paper
• A correlation between decreased parathyroid α-Klotho and fibroblast growth factor receptor 1 expression with pathological category and parathyroid gland volume in dialysis patients

  2015cites this paper
• Disease Parathyroid Hormone : Critical Bridge Between Bone Metabolism and Cardiovascular

  2014cites this paper
• Vitamin D and Parathyroid Hormone Levels in Prediction of the Prevalence of Cerebrovascular Accident in Geriatric Patients

  2014cites this paper
• Optimal management of hyperphosphatemia in end-stage renal disease: an Indian perspective

  2014cites this paper
• Parathyroid hormone: critical bridge between bone metabolism and cardiovascular disease.

  2014cites this paper
• Parathyroidectomy and heart rate variability in patients with stage 5 CKD.

  2013influential citation
• In-hospital mortality in patients with renal dysfunction admitted for myocardial infarction: the Emilia-Romagna region of Italy database of hospital admissions

  2013cites this paper
• Significant Independent Predictors of Vitamin D Deficiency in Inpatients and Outpatients of a Nephrology Unit

  2013cites this paper
• Vitamin D and Kidney

  2013cites this paper
• The association of parathyroid hormone with ESRD and pre-ESRD mortality in the Kidney Early Evaluation Program.

  2012cites this paper
• Cinacalcet effects on the perioperative course of patients with secondary hyperparathyroidism

  2012cites this paper
• Uremia-associated cardiovascular and lung injury

  2012cites this paper
• Secondary Hyperparathyroidism: Benign Bystander or Culpable Contributor to Adverse Health Outcomes?

  2012cites this paper
• Impact of Vitamin D Deficiency on Systemic Inflammatory Markers and Left Ventricular Functions in Rachitic Infants

  2012cites this paper
• Elevated serum parathyroid hormone is a heart risk factor in hemodialysis patients

  2012cites this paper
• Differences between hospitals in attainment of parathyroid hormone treatment targets in chronic kidney disease do not reflect differences in quality of care

  2012cites this paper
• Glomerular filtration rate is related to severity of obstructive coronary artery disease in patients undergoing coronary angiography

  2012cites this paper